Press Release | Aug 20, 2018

After a successful cross-country collaboration with the HydraFacial Nation World Tour, Colorescience®, the leading dermatologist-recommended skincare and cosmetics company, is excited to announce the next partnership between the two companies beginning in August 2018 that fully integrates Colorescience®’s into the PERK experience.

Press Release | Jul 09, 2018

Solsys Medical, LLC (“Solsys”) (formerly known and doing business as Soluble Systems, LLC) (“Soluble Systems”), which markets TheraSkin®, a cellular and tissue-based product for regenerative wound healing, announced today the appointment of Arti Balar Masturzo, M.D as its Chief Medical Officer.

News | May 18, 2018

Innovative Health announced on Monday that it scored FDA clearance to reprocess St. Jude Medical’s ViewFlex Xtra Diagnostic Ultrasound Catheter. “Reprocessing is changing,” Rick Ferreira, CEO of Innovative Health, told HCB News. “It used to be about mimicking manufacturer technique on low-complexity devices late in their life cycle. SUD reprocessing is increasingly about understanding clinical

Press Release | Apr 26, 2018

Genoptix, Inc., a leading oncology diagnostic laboratory today announced that Rosetta Genomics’ stockholders have approved the acquisition of Rosetta Genomics by Genoptix. Genoptix will immediately begin marketing, selling and distributing the complete Rosetta Genomics portfolio and will ensure the uninterrupted availability of these important products for physicians and patients. Genoptix previously purchased Rosetta Genomics’ precision

News | Mar 13, 2018

Easing adoption, accelerating commoditization and lowering costs. That’s how it works everywhere else. Why not in healthcare? In my interview of experts from Innovative Health, the largest U.S. medical device reprocessor specializing in cardiology, they all reinforced the same point: hospital decision-makers still must turn the tables on the manufacturer.

Pages 1 8 9 10 11 12 13 14 15